Skip to content

Effect of diabetes prevention program using Flash Glucose Monitoring

Effect of diabetes prevention program using Flash Glucose Monitoring - Effect of diabetes prevention program using Flash Glucose Monitoring

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042516
Enrollment
60
Registered
2020-11-24
Start date
2020-11-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prediabetes

Interventions

FGM + health guidance group (with FGM) This is a diabetes prevention program in which a public health nurse gives health guidance to a subject seven times in three months via a smartphone based on ac

Sponsors

Panasonic Health Insurance Organization,Health care center
Lead Sponsor
Panasonic Health Insurance Organization,Matsushita Memorial Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Regular health checkups and health insurance union staff with HbA1c 5.6-6.4% in the 2020 regular health checkup results 2) Men and women over 20 years old (at the time of obtaining consent) 3) Subjects who have written consent to participate in this study 4) Those who can wear FGM 5) You must agree to the health management guidelines of Panasonic Health Insurance. 6) Those who meet all of the following diabetes prevention program participation requirements - Do not take any medication related to diabetes treatment -Do not take medication for diseases other than diabetes (if you are taking medication, diabetes prevention plan) Check with your doctor about your participation in the program) - You must have a contactable email address -Own a smartphone that can download apps (so-called feature phones / tablet devices cannot be substituted) -You must own a computer connected to the Internet at home (a tablet terminal cannot be used as a substitute).

Exclusion criteria

Exclusion criteria: 1) Those judged by the doctor to be contraindicated in exercise therapy (NYHA 2nd degree or higher heart disease, etc.) 2) Pregnant or lactating women 3) Those who are equipped with other implantable medical devices such as pacemakers 4) When the doctor deems it inappropriate in terms of safety, etc.

Design outcomes

Primary

MeasureTime frame
Comparison of the amount of change in each measurement timing(after the completion of health guidance, the next year's regular health checkup) of HbA1c between the FGM + health guidance group and the health guidance group

Secondary

MeasureTime frame
The following items will be compared before and after the intervention in both groups (FGM + health guidance group and health guidance group). Fasting blood glucose level, uric acid, total cholesterol, triglyceride, HDL cholesterol, LDL cholesterol, renal function, insulin, body weight, BMI, blood pressure, body composition (muscle mass, fat mass), BDHQ. Comparison of 24-hour average blood glucose level and Time in range between night shift workers and non-night shift workers. Comparison of 24-hour mean blood glucose and Time in range before and after intervention in FGM + health guidance group.

Countries

Japan

Contacts

Public ContactKEISUKE KUNIEDA

Panasonic Health Insurance Organization,Health care center Health care center

keisuke.kunieda@jp.panasonic.com06-6992-7070

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026